Financials
Financials — What the Numbers Say
Figures converted from EUR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.
1. Financials in One Page
Topicus is a European vertical-market-software (VMS) compounder running the Constellation Software playbook: dozens of small, mission-critical software businesses bolted together, run decentrally, and funded by their own recurring cash flows. Revenue has compounded from $408M in FY2018 to $1,824M in FY2025 — a 7-year CAGR near 24% — with EBITDA margins parked in a tight 27-33% band, FCF margins of 21-30%, and capex consistently under 1% of sales. The reason GAAP earnings look ugly (FY2025 net income $49M, FY2021 net income –$2,134M) is well-known accounting noise: non-cash IFRS finance charges tied to Topicus.B Exchangeable Shares and CSI Class A Preferred units that move with the share price, plus heavy amortization of acquired intangibles. Look at cash: operating cash flow of $485M and free cash flow of $472M in FY2025 — both records. The balance sheet flipped from net-debt-light ($151M, 0.3x EBITDA at YE 2024) to $545M (0.99x EBITDA) because management drew ~$520M in new debt to fund $332M of acquisitions and end the year with $384M of cash. The headline valuation looks expensive on P/E (158x on depressed earnings) but reasonable on the cash metrics: EV/EBITDA ~17x, P/FCF ~16-18x, EV/Sales ~4.7x — broadly in line with parent Constellation (CSU at EV/EBITDA 17.4x, EV/Sales 3.5x) and well below DSGX or TYL. The single financial metric that matters most right now is ROIC on incremental acquisition capital — the entire thesis rises or falls on whether Topicus can keep deploying $250-500M of cash a year into businesses that earn high teens returns.
Revenue FY2025 ($M)
Revenue Growth YoY
Operating Margin
Free Cash Flow ($M)
FCF Margin
Net Debt / EBITDA
ROIC FY2025
EV / EBITDA (LTM)
Read this once. Net income is the wrong P&L line for Topicus. The company's reported net income is depressed by non-cash IFRS charges (mark-to-market on Topicus.B and CSI preferred, plus acquired-intangible amortization) that have nothing to do with cash earnings. Throughout this page, the binding earnings number is operating cash flow and free cash flow, not GAAP net income or EPS.
2. Revenue, Margins, and Earnings Power
How Topicus makes money. Topicus owns ~120 European VMS businesses across healthcare, finance, education, government, and automotive. Each business sells mission-critical software to a niche industry where switching costs are high; revenue is a mix of recurring software licenses, maintenance/SaaS subscriptions, transactional fees (payments, financing), and a thin layer of professional services. Recurring + maintenance is the dominant slice — the rest is byproduct or runoff.
The growth pattern. Revenue compounded at 23.9% CAGR over seven years — a function of both organic growth (mid-single digits, per management commentary) and a steady drumbeat of bolt-on acquisitions ($53M in FY2018 rising to $332M in FY2025). The FY2021 step-up (+39%) and FY2025 step-up (+36%) both coincided with larger deal years. Operating income roughly tracked revenue but with two notable wobbles: FY2022 op income flatlined despite +16% revenue (heavy SG&A from acquisitions + integration friction) and FY2025 op income grew only +28% despite +36% revenue.
Margin interpretation. Margins are remarkably flat for a roll-up — that's the whole point of Constellation-style decentralization: don't centralize, don't squeeze for synergies, don't break the businesses. EBITDA margin has lived at 28-33% for eight years; FCF margin between 21-30%. The visible margin compression in FY2022 was acquisition-cost-driven (FY2021 deals weren't yet earning their full keep). FY2024 saw the strongest margin set (FCF margin 26.2%) and FY2025 held the line. Gross margin around 36% is structurally below pure-software peers like Descartes (77%) or Roper (69%) because Topicus's mix includes labour-intensive maintenance and professional services from acquired companies — that's a recurring point of confusion for first-time readers.
Recent trajectory: quarterly
Quarterly growth has re-accelerated through FY2025: revenue YoY grew 16% in 1Q25, 20% in 2Q25, 24% in 3Q25, 20% in 4Q25, and 23% in 1Q26. That re-acceleration matters because it is the first sustained pickup since the FY2022 deceleration and pushes the latest TTM growth rate to roughly 21%. Operating margin is seasonal (Q4 is always the strongest, ~17-20%; Q1-Q2 sits 13-15%) and the recent quarters are tracking the prior year's pattern, not breaking it.
3. Cash Flow and Earnings Quality
Free cash flow definition (read once). Free cash flow is the cash a business generates from operations after the spending required to keep its current asset base intact. For Topicus, the formula is straightforward: operating cash flow minus capital expenditure (capex). It excludes acquisition spending — those are growth investments, not maintenance.
The huge net-income-to-cash gap is structural, not a red flag. Notice the chart: net income tracks far below operating cash flow every year, and was deeply negative in FY2021 (–$2,517M consolidated, including the Topicus.B mark-to-market) and disproportionately low in FY2025 ($49M vs $472M FCF). The drivers of that gap, in order of size:
- Acquired-intangible amortization (~$240M in FY2025, ~$176M in FY2024) — a non-cash IFRS charge for customer-relationship and software amortization on businesses Topicus has bought. Real economic charge if the asset wastes, but cash already left when the deal closed.
- Topicus.B Exchangeable Shares mark-to-market — these CSU-held exchangeable shares are accounted for as a liability under IFRS, marked to fair value each quarter; when TOI's share price rises, IFRS creates a finance charge that hits pretax income but produces no cash outflow.
- CSI Class A Preferred Units — similar dynamic; non-cash fair-value adjustments.
- Working-capital benefit — Topicus runs a structurally negative working-capital cycle (deferred revenue from prepaid licences/subscriptions is large vs receivables), so revenue growth releases cash rather than absorbing it.
The gap between pretax income ($127M) and operating income ($274M) in FY2025 is almost entirely items 2–3. They are real to the GAAP statements but should not be deducted from earnings power.
Capex is trivial. Topicus spent $12.5M on capex in FY2025 against $1,824M of revenue — 0.7%. Capital intensity at the operating-company level is genuinely low; the real "growth capex" sits in the acquisitions line, which the cash-flow statement classifies under investing.
| Cash-flow distortion | FY2025 ($M) | Cash or non-cash? | What it tells you |
|---|---|---|---|
| Net income | 49.1 | Cash-equivalent? No | Distorted by items below |
| Depreciation & amortization | 240.0 | Non-cash | Mostly acquired-intangible amortization |
| Working-capital benefit | ~+100 (implied) | Cash | Deferred revenue grows with sales |
| Capex | -12.5 | Cash | Tiny; under 1% of revenue |
| Acquisitions | -331.9 | Cash | Investing line; the "real" growth capex |
| Dividends paid | 0 | n/a | None in FY2025 (FY2024 paid $132.6M special) |
| Debt drawn (net) | +497.9 | Cash | Funded the acquisition step-up |
Bottom line on earnings quality. Operating cash flow has been 0.96–0.98x of itself converted into FCF every year for eight years. The OCF/EBITDA ratio sits at ~0.94 (485/515 in FY2025). Cash is real; ignore reported net income for valuation work and use FCF or operating-income-after-tax.
4. Balance Sheet and Financial Resilience
What changed in FY2025. Net debt nearly tripled in a single year ($151M → $545M) and total debt more than doubled ($366M → $929M). The cash-flow statement shows why: management drew $520M of new debt, repaid only $22M, and spent $332M on acquisitions while ending with $384M of cash on hand. This is strategic rearmament for M&A, not distress. Leverage at 0.99x EBITDA is still firmly investment-grade by software-industry norms (and well below the 2-3x parent CSU has carried at points) but it is the highest the company has run since the spin-off, and it tilts the next-12-month story toward acquisition deployment, not balance-sheet repair.
Working capital — the structural cash machine. Current ratio is 0.62, which would normally trigger a red flag. For Topicus it is by design: deferred revenue from prepaid annual licences and subscriptions sits in current liabilities (alongside other accrued items), making the ratio look weak while the underlying cash dynamic is actively favourable. Receivables are $270M (DSO ~54 days), inventory is immaterial ($8M; this is a software business), and accounts payable of $429M largely reflects deferred revenue and prepaid customer balances. The negative working-capital posture means revenue growth funds itself rather than absorbing cash.
Intangibles dominate the asset side. $1,411M of goodwill and acquired-intangibles against $2,953M of total assets (48%), down from 72% in FY2018. Tangible book value per share remains negative (–$5.28 implied in FY2025) — entirely normal for a roll-up that has paid premiums for software businesses funded with debt and exchangeable shares.
Resilience watchpoint. With short-term debt of $406M and only $384M of cash, Topicus is not over-leveraged but it is no longer the cash-net-of-debt company it was at the end of FY2023 ($198M cash, $120M net debt). Interest coverage is still very strong (operating income $274M vs implied interest expense ~$45-60M; FY2024 interest paid was ~$22M), but the FY2025 debt-funded acquisition pivot raises sensitivity to rate moves and to whether the new acquisitions deliver expected cash returns.
5. Returns, Reinvestment, and Capital Allocation
Why returns matter most for this stock. Topicus is a compounder. The thesis is not "stable EPS at 15x" — it is "management redeploys ~75% of cash flow into new acquisitions at high-teens ROIC, year after year." If incremental ROIC stays in the mid-teens, intrinsic value compounds at growth + dividends + return-on-redeployed-cash; if it slips into single digits, the whole framework loses its rationale.
Interpretation. FY2018's 32% ROIC is a small-base anomaly; the durable corridor since the 2021 spin-off has been roughly 10-16% ROIC, with FY2024 hitting 15.8% and FY2025 dipping to 10.4%. The FY2025 dip is largely a denominator effect — invested capital ballooned with the debt-funded acquisitions late in the year, while the new businesses haven't yet contributed a full year of operating income. By the same logic, FY2025 ROE printed 7.6% on depressed (accounting-noise-impaired) net income; the operating-income-based return on tangible capital is closer to 18%. ROE through the cycle has averaged ~15-20% post-spin, consistent with mid-teens compounding.
What management does with cash.
- Acquisitions are the dominant use — $1.23B cumulative over FY2018-FY2025, peaking at $332M in FY2025 and $268M in FY2021. The acquisition pace is lumpy but persistent; it tracks the M&A pipeline more than the cash on hand.
- Special dividends are episodic, not recurring: $61.8M ($0.97/share) in 2021 right after the spin, then $132.6M ($1.60/share) in 2024. No regular dividend policy.
- Buybacks: none. No share repurchases are recorded in the cash-flow statement across the eight-year span. Share count is essentially static (basic shares 79-83M from FY2022 onward; fully diluted 129.8M including Topicus.B exchangeables).
- Capex is trivial (~0.6-0.9% of revenue).
Per-share progress is the right scorecard. FCF per share has gone from $1.55 in FY2020 to $3.64 in FY2025 — a 18.6% CAGR over five years, beating revenue growth on a per-share basis because dilution is being kept under control. Book value per share rose 66% in FY2025 ($4.25 → $7.07) on retained earnings and re-measurement of Topicus.B liability.
Capital-allocation judgment. Management is reinvesting at attractive returns, not masking weak economics. Per-share FCF compounding mid-to-high teens since the spin is the highest-quality signal that the compounder model is working. The choice not to buy back stock — even when the share price corrected in 2022-2023 — is consistent with Constellation's stated preference for acquisitions over buybacks because acquisition returns clear a much higher hurdle than even cheap repurchases.
6. Segment and Unit Economics
The available data file data/financials/segment.json does not contain a structured segment-revenue breakdown for Topicus. From the company's published filings, the operating-group split mirrors CSU: management groups its acquisitions by vertical and geography but discloses limited segment-level financials beyond aggregate organic vs. acquired growth and a high-level revenue mix across recurring software, transaction processing, services and licenses.
What the filings do tell us:
- Revenue composition. Maintenance + recurring + SaaS revenue is the majority share (typically 70-80% of revenue for VMS roll-ups of this profile), professional services in the 10-15% range, hardware/license in single digits, and transactional payments/financing revenue an increasingly meaningful slice through subsidiaries like Total Specific Solutions and Topicus Finance.
- Geography. Operations are concentrated in the Netherlands (the historical core), Belgium, Germany, the UK, the Nordics, and selected DACH/Iberian footprints. North American exposure is limited and not the growth engine.
- Vertical concentration. Healthcare and finance are the two largest verticals by employees and revenue, with government, education, automotive, and legal each representing meaningful but smaller slices.
Without disclosed segment-level operating margins, we cannot isolate which segment carries the economics. Investor-facing reporting parallels CSU's habit of disclosing segment data only in broad strokes. The most informative organic-growth proxy is the gap between reported revenue growth and acquisition spending: FY2025's +19.9% growth on $332M of M&A implies low-to-mid single-digit organic growth, in line with the broader VMS roll-up cohort.
Segment disclosure gap. A real, decision-useful segment view of healthcare vs. finance vs. government margins would matter for valuation. Topicus, like its parent CSU, deliberately keeps this aggregate. Reader should not over-weight segment-driven narratives.
7. Valuation and Market Expectations
The setup. Topicus's TSXV ticker closed at C$91.81 on 2026-05-14 (data/prices/daily.json). With 129.8M fully diluted shares (basic + Topicus.B Exchangeable), market cap ≈ C$11.92B ≈ $8.7B (or ~€7.4B at spot FX). LTM revenue $1,824M; LTM EBITDA ~$515M; LTM FCF $472M; net debt $545M; enterprise value ≈ $9.2B.
Pick the right yardstick. For Topicus, P/E is misleading because earnings are depressed by non-cash IFRS charges; P/FCF and EV/EBITDA are the right primary lenses, with EV/Sales as a sanity check against the peer set.
Reading the history. TOI has traded in an EV/EBITDA band of 16-29x since the 2021 spin, with FY2025 sitting at the low end (16.7x). P/FCF has compressed steadily from ~21x to ~16x — implying the market has not paid more for the growth the company has actually delivered. EV/Sales sits at 4.7x, below the post-spin average around 5.2x. On every cash-relevant multiple the stock is at or below its post-spin historical range despite FY2025 being a record cash year and growth re-accelerating. That is the bull's strongest valuation argument.
Fair Value and Quality Score are not available in this run's rankings dataset (the diagnostic probe was missing).
A simple bear/base/bull frame on FCF
Applied to the current 129.8M share count: Bear = $47/share, Base = $82/share, Bull = $129/share — versus a current C$91.81 (~$67). The current price sits about a third of the way between bear and base — not a screamingly cheap setup, but not extended either, especially against the FY2024-2025 evidence of cash compounding.
Consensus context. Sell-side coverage is sparse (3-4 analysts, mostly Canadian banks). TipRanks/Investing.com show analyst average price targets in the C$140-198 range with a "Buy/Strong Buy" consensus and 50%+ implied upside — i.e., consensus is closer to the bull case than the base case above. Treat this as a function of sparse coverage rather than firm signal.
8. Peer Financial Comparison
Topicus is one of the publicly traded VMS roll-ups. The natural peer set is:
- CSU — parent Constellation Software (TSX), same playbook at 8x scale
- LMN — Lumine Group, the other CSU spin-off, communications-focused
- ROP — Roper Technologies, US-listed serial acquirer at ~$8B revenue
- TYL — Tyler Technologies, US public-sector VMS specialist
- DSGX — Descartes Systems Group, logistics-focused VMS
Read the table. Topicus screens as the fastest-growing of the cohort (+20% vs 9-15% for peers), with EBITDA and FCF margins broadly in line with parent CSU. ROIC at 10.4% trails LMN (14.0%) and CSU (11.7%) — partly the FY2025 acquisition-denominator effect noted earlier; through FY2024 ROIC was 15.8%, comfortably above CSU. Balance sheet is more levered than DSGX/TYL/LMN (which carry net cash) but well under ROP's 2.6x and similar to CSU. On valuation, TOI trades roughly in line with CSU on EV/EBITDA, slightly cheaper on EV/Sales, and at the lowest P/FCF in the peer set — consistent with the historical premium TOI commands shrinking over the last 12 months.
The peer gap that matters: Topicus delivers the fastest growth at peer-average margins for a discount to parent CSU on P/FCF and EV/Sales. If the compounder model still works, that gap is harder to defend on operating metrics alone.
9. What to Watch in the Financials
Closing. The financials confirm Topicus is doing what a Constellation-style compounder should do: growing revenue mid-to-high teens organically-plus-acquired, generating record free cash flow, deploying that cash into more acquisitions, and keeping per-share metrics moving in the right direction. The financials contradict the headline P/E narrative — the 158x number is an artefact of IFRS noise, not of a business that has lost earnings power. The one place the financials are not yet emphatic is whether the FY2025 acquisition burst will earn its keep: a year of debt-funded M&A always lowers measured ROIC in the short term, and we need to see operating margin and FCF margin hold through FY2026 to confirm the new businesses are integrating without dilution.
The first financial metric to watch is ROIC trajectory through FY2026 — specifically whether ROIC recovers from the FY2025 dip (10.4%) back toward the FY2024 level (15.8%) as the acquired businesses contribute full-year operating income. If ROIC stays sub-12% for two consecutive years, the compounder story is in question; if it bounces, the FY2025 acquisition step-up will look like the right move.